SCHEMBL25759506

SCHEMBL25759506

CCOC(O)Cc1ccc(N)cc1S(=O)(=O)Nc1ccc(C)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 4/20 0.43
ALDH1A1 P00352 6/20 0.42
MAPT P10636 4/20 0.42
RECQL P46063 2/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
KDM4E B2RXH2 1/20 0.42
POLB P06746 1/20 0.42
CASP6 P55212 1/20 0.42
ELAVL1 Q15717 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
LMNA P02545 4/20 0.40
SMN1; SMN2 Q16637 4/20 0.40
HSD17B10 Q99714 1/20 0.40
HPGD P15428 2/20 0.40
CDK1 P06493 1/20 0.40
CCNB1 P14635 1/20 0.40
CCNA2 P20248 1/20 0.40
CCND1 P24385 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25759512 0.90 MAPT (0.47) GAAALDH1A1MAPTMEN1KMT2A
SCHEMBL25759435 0.90 GAA (0.43) GAAALDH1A1MAPTMEN1KMT2A
SCHEMBL25754797 0.82 GAA (0.50) GAAALDH1A1MAPTRECQLMEN1
SCHEMBL23846466 0.80 LMNA (0.47) GAAALDH1A1MAPTRECQLMEN1
SCHEMBL25759510 0.71 MAPT (0.47) GAAALDH1A1MAPTMEN1KMT2A
SCHEMBL23846511 0.71 NHERF1 (0.49) GAAALDH1A1MAPTMEN1KMT2A
SCHEMBL23846503 0.71 SMN1; SMN2 (0.71) GAAALDH1A1RECQLMEN1KMT2A
SCHEMBL25754833 0.71 PKM (0.54) GAAALDH1A1MAPTMEN1KMT2A
SCHEMBL25754837 0.71 MAPT (0.58) GAAALDH1A1MAPTMEN1KMT2A
SCHEMBL17774566 0.70 GAA (0.76) GAAALDH1A1MAPTRECQLMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230174523-A1 BENZENESULFONAMIDE DERIVATIVES AS TRAP1 MODULATORS AND USES THEREOF AMATHUS THERAPEUTICS, INC. (US) 2023-06-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230174523-A1 BENZENESULFONAMIDE DERIVATIVES AS TRAP1 MODULATORS AND USES THEREOF TRAP1, PINK1, TP53BP1 GAA 1667/4885ALDH1A1 2569/4885MAPT 89/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.